Entering text into the input field will update the search result below

Express Scripts will list Viatris' Semglee insulin biosimilar on preferred formulary

Oct. 20, 2021 12:27 PM ETViatris Inc. (VTRS) StockCIBy: Jonathan Block, SA News Editor3 Comments

Insulin injection needle or pen for use by diabetics

digicomphoto/iStock via Getty Images

  • Pharmacy benefit manager ("PBM") Express Scripts will list Viatris' (VTRS +2.9%) insulin biosimilar Semglee (insulin glargine-yfgn) on its national preferred formulary.
  • The coverage begins on Jan. 1, 2022.
  • Express Scripts said the move will lead

Recommended For You

About VTRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VTRS--
Viatris Inc.